This document discusses parathyroid tumors and calcium regulation by the parathyroid hormone (PTH). It covers primary, secondary, and tertiary hyperparathyroidism, their causes, symptoms, and treatments. Key points include:
- PTH levels are regulated by calcium levels through a feedback loop involving the calcium sensing receptor.
- Primary hyperparathyroidism is usually caused by a parathyroid adenoma and is often asymptomatic. Surgery is the only cure.
- Secondary hyperparathyroidism is caused by chronic kidney disease or vitamin D deficiency and leads to hyperplasia of all four parathyroid glands. It can be managed medically but may require surgery.
- Tert
Testicular tumors are rare.
1 – 2 % of all malignant tumors.
Most common malignancy in men in the 15 to 35 year age group.
Benign lesions represent a greater percentage of cases in children than in adults.
Most curable solid neoplasm
hyperparathyroidism with detailed discussion of primary Primary hyperparathyroidism, presentation , workup management & surgery & post operative management
Testicular tumors are rare.
1 – 2 % of all malignant tumors.
Most common malignancy in men in the 15 to 35 year age group.
Benign lesions represent a greater percentage of cases in children than in adults.
Most curable solid neoplasm
hyperparathyroidism with detailed discussion of primary Primary hyperparathyroidism, presentation , workup management & surgery & post operative management
Hyperparathyroidism exists in three different forms: primary, secondary and tertiary. Primary hyperparathyroidism (pHPT) is the most frequent pathological condition of the parathyroid glands and one of the most frequent endocrine disorders overall. The most probable location of parathyroid gland is posterior to the thyroid gland. The parathyroid glands produce parathyroid hormone (PTH), which is important for maintaining calcium, phosphate and vitamin D homeostasis, and ultimately bone health.
Primary hyperparathyroidism is characterized by increased production and secretion of parathyroid hormone. This condition causes nephrocalcinosis, urolithiasis, osteoporosis, gastrointestinal disturbances, neuromuscular manifestation and neuropsychiatric disorders. Parathyroidectomy is the only curative treatment for pHPT. pHPT is typically caused by a solitary parathyroid adenoma (80%-90%), hyperplasia (10%) and less frequently parathyroid carcinoma (5%).
Secondary hyperparathyroidism develops as a consequent to a chronic hypocalcemic condition that can be caused by renal failure, gastroinstinal malabsorption, dietary rickets and ingestion of drugs. Secondary hyperparathyroidism is a frequent and serious complication in haemodialysis patients. Tertiary hyperparathyroidism is a condition where parathyroid hyperplasia, secondary to chronic hypocalcemia, becomes autonomous with development of hypercalcemia. Tertiary hyperparathyroidism is used to designate hyperparathyroidism that persists or develops after renal transplantation.
Localization of hyperfunctioning parathyroid tissue (adenomas or hyperplasia) in primary hyperparathyroidism is useful before surgery to help the surgeon localize the lesion, thus shortening the time of the procedure. Parathyroid glands can be imaged with multiple modalities, including scintigraphy, high-resolution ultrasonograhy, thin-section CT and MRI. Parathyroid scintigraphy may also be indicated for localization of hyperfunctioning parathyroid tissue in patients with persistent or
recurrent disease. For this situation scintigraphy is superior to any other radiological modalities, including MRI, CT scan, ultrasonography combined with needle aspiration and also some invasive techniques like arteriography, selective venography and mediastinoscopy.
This presentation is about Parathyroid Disorders which are hypo and hyperparathyroidism and their relationship to teeth and oral cavity including oral and dental manifestation of these disorders , and correct management patients seeking dental care with these disorders.
This presentation covers different thyroid and parathyroid disorder, their aetiology, clinical manifestation, signs, symptoms, treatments and case studies.
a presentation dealing with thyroid carcinomas including papillary , follicular ,medullary and anaplastic carcinoma ..
also there is a very small mention of lymphoma of the thyroid gland.
Csf rhinorrhea repair- case report and discussionENT Resident
this topic deals with a case report of CSF rhinorrhea and the discussion part deals with its various types, usefulness of imaging and various tests in the diagnosis and the various treatment options. it was presented in Pakistan,Lahore at a ENT regional conference.
this presentation deals with the real time diagnostic dilemmas of aspiration in in third world countries and suggest some remedies to counter the problems. this presentation also touch upon aspiration issues in children especially neonates and remedies to avoid it. obviously a presentation cannot substitute detail reading but it will help you have an outline of how to manage such cases.
otosclerosis....
stapedectomy vs stapedotomy
complication of otosclerotic surgery
management of otosclerotic surgery complications
techniques
latest trends
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. CALCIUM –PTH
Feed back regulation
Sigmoid curve PTH-Calcium curve
Calcium sensing receptor CSR
‘Set point’ ---shifting right with Lithium,CRF
--- shifting left with early renal failure
PTH is secreted intermittently so normocalcaemia
can be found! T1/2 = 2mins
Vit D deficiency can also lead to normocalcaemia
3. Manifestation of hypercalcaemia
Muscle weakness
Muscle and bone aches and pains
Depression
Constipation
Tiredness
Peptic ulceration
Pancreatitis
Renal impairment
Nephrogenic diabetes insipidus
Nephrolithiasis
Shortened QT interval
Band keratopathy
Thirst and polyuria
7. Adenoma and PTHrP ( PTH)
Bones,stones,groans,psychic moans
found mostly during workup of
osteopenia,osteoporosis and nephrolithiasis
Osteitis fibrosa cystica is a condition of chronic
disease (usually with 2ndary and tertiary )
Usually present in 60s
2:1 female to male
24 hrs urinary calcium is used
Adenoma has equal frequency in superior and
inferior glands!
8. Treatment include medical and surgical BUT
surgery is curative
In symptomatic pts decision is simple
In asymptomatic NIH criteria used
Less then 50 years old
Unable to be effectively followed up
Serum calcium >1.0 mg/dL above the normal range
Urinary calcium >400 mg/24 hours
30% decrease in renal function
Complications of HPT: nephrocalcinosis,
osteoporosis (T-score o2.5 s.d. at lumbar spine, hip
or wrist)
Severe psychoneurologic disorder
10. Chronic PTH stimulus but relieved on removing
the stimulus
Causes
CRF
Vit D def
Intestinal malabsorption
CCF
HTN
Parenteral nutrition
Lithium
When nothing adds up than think LITHIUM!
( urinary Calcium,no stones, PTH)
11. Four glands hyperplasia happens
Sometimes adenoma can also form or a nodular
hyperplasia happens
Biopsy glands!
Renal disease treated by phosphate binders
,calcitriol --- subtotal parathyroidectomy
13. Refractory secondary hyperparathyroidism
Set point irreversibly shifted to right
Subtotal parathyroidectomy (leave 20-30gm)
Think when renal transplant doesn’t get PTH level
down!
Think when dialysis is not bringing PTH down!
Think when PTH high, in spite withdrawing lithium !
During operation wait 25 min (not 10 min) to draw
PTH for 50% reduction after removal of gland to
rule out any remaining glands!
15. Sporadic still a more common cause
FAMILIAL HYPERCALCAEMIC
HYPOCALCIURIA
AUTO DOMINANT MILD HYPER PTH
NEONATAL SEVERE HYPER PTH
MEN 1
MEN 2A
HPT JAW SYNDROME
FAMILIAL ISOLATED HYPER PTH
HPT JAW SYND – related to carcinoma of PTH!
Subtotal resection will n
As polyclonal proliferatio
Tumor based, so
subtotal resection
will cure
asymptomatic
17. < 1%
High incidence in Japan and Italy
45—51 yrs
More symptomatic
Radiation exposure be a cause
Cyclin D1 on chromosome 31,Rb genes, p53
genes
radioresistant
Treatment _ enbloc resection + hemithyroidectomy
Deaths of these pts are due to hypercalcemia!
19. PREOPERATIVE
Scintigraphy – Tc99m sestamibi(double phase
scan)
_ substraction technique via I 123
..best mode
Doppler Ultrasound _ for ectopic glands
FDG PET _ for ectopic glands
MRI /CT scan
Venous sampling
Experience surgeon can identify 95% of glands: all
above means 80%!
20. INTRAOPERATIVE
GAMMA PROBE
METHYLENE BLUE
FROZEN SECTION
INTRAOPERATIVE PTH (ioPTH)
Expensive
A measure of success of procedure
Donot work well in hyperplasia situation
Sample at T0,T5 and T10
50% decrease in value means success
24. Targeted approach … gamma probe for adenoma
only aided by ioPTH
Four gland exploration … in glandular hyperplasia
aided by frozen section and ioPTH
26. Superior gland _
deep to RLN and inf throid artery at retrothyroid
area
Within 1cm of cricothyroid
Deep to cricothyroid
Darker body with vessel inside a fat
Inferior gland
Region of Thyrothymic tract(Medial to RLN)
Tracheoesophageal groove
Within thymus
Within thyroid
Mediastinum
Lateral to carotids
Pyriform fossa
27. Thymic exploration
80 % rule – explore the opposite thymus if adenoma
found within one thymus
Thyroid exploration
For subcapsular or intraglandular PT --- ioPTH is
used to find the side
1st thorough search frm hyoid to superior
mediatinum
Than excise lower 2/3rd thyroid or do lobectomy
Dice on table and find the missing PT
Look other side when cant find gland in normal
location at first!
No search after finding an adenoma if only one gland
is missing!
No search after bilateral exploration,bilateral thymic
29. Autotransplant in hyperplasia cases
60mg diced in 15-20 1 cubic mm pieces in non-
dominant brachioradialis marked with ligaclips
Rest cryopreserved for failure cases
31. TEMPORARY THRESHOLD SHIFT( nerves and
muscle are accustomed to high calcium :so pt
become symptomatic)
HUNGRY BONE SYND ( fall in PTH causes bone
to take in calcium)
days
Temporary hypoparathyroidism
weeks
Permenant hypoparathyroidism
>3 months
Only symptomatic hypocalcemia be treated !
If not resolving check magnesium!
33. Life threatening condition (confusion-coma)
> 3.5 mmol/l
Rehydrate with NaCl
Loop diuretics
Calcitonin will buy 72 hrs
Steriods (decrease vit D conversion)
Gallium and mithramycin (cytotoxic to osteoclast)
Bisphosphonate main stay
treatment but slow onset
pamidronate 28 days lasting
effect
Will buy minutes